Mackintosh D, Mason R M
Department of Biochemistry, Charing Cross and Westminster Medical School, London, U.K.
Biochim Biophys Acta. 1988 Mar 17;964(3):295-302. doi: 10.1016/0304-4165(88)90029-3.
(1) Pharmacological concentrations (greater than 10(-5) M) of 17 beta-oestradiol inhibited 35S-labelled proteoglycan synthesis in bovine articular cartilage explant cultures. They also inhibited 35S-labelled proteoglycan synthesis and 3H-labelled protein synthesis in cell cultures of chondrocytes from bovine articular cartilage and Swarm rat chondrosarcoma. Maximal inhibition was about 30-50%. Physiological concentrations (10(-9)-10(-8) M) of oestradiol had no effect on the synthesis of either protein or proteoglycan. (2) The inhibitory action of high concentrations of oestradiol on these biosynthetic pathways is not common to all steroids since 10(-4) M cortisol had no effect on articular chondrocyte cell cultures. 10(-4) M testosterone had a similar action to oestradiol. (3) Neither physiological nor pharmacological concentrations of 17 beta-oestradiol had any effect on 35S-labelled proteoglycan turnover in the cartilage explant system. (4) 10(-5) M oestradiol inhibited cell division in cultures of articular chondrocytes which had entered the log growth phase. 10(-7) M oestradiol had no effect on articular chondrocyte growth. (5) In male rats implanted with silastic capsules releasing 17 beta-oestradiol, increase in body weight was retarded by about 25% over a period of 6 weeks, compared to control rats. Rat chondrosarcoma grew to the same size in oestrogen-treated rats as it did in controls. (6) Oestrogen receptors could not be detected in freshly isolated bovine articular chondrocytes or in rat chondrosarcoma. (7) In conclusion, neither the mitotic rate of articular chondrocytes nor their proteoglycan metabolism is under the direct physiological control of oestradiol. Growth and biosynthetic activity of the rat chondrosarcoma chondrocytes are independent of either direct control by the hormone or control effected by oestradiol regulation of a second hormone or growth factor.
(1) 药理浓度(大于10⁻⁵ M)的17β-雌二醇抑制牛关节软骨外植体培养物中³⁵S标记的蛋白聚糖合成。它还抑制来自牛关节软骨和斯旺大鼠软骨肉瘤的软骨细胞培养物中³⁵S标记的蛋白聚糖合成和³H标记的蛋白质合成。最大抑制率约为30% - 50%。生理浓度(10⁻⁹ - 10⁻⁸ M)的雌二醇对蛋白质或蛋白聚糖的合成均无影响。(2) 高浓度雌二醇对这些生物合成途径的抑制作用并非所有类固醇都有,因为10⁻⁴ M皮质醇对关节软骨细胞培养物无影响。10⁻⁴ M睾酮具有与雌二醇类似的作用。(3) 生理浓度和药理浓度的17β-雌二醇对软骨外植体系统中³⁵S标记的蛋白聚糖周转均无影响。(4) 10⁻⁵ M雌二醇抑制已进入对数生长期的关节软骨细胞培养物中的细胞分裂。10⁻⁷ M雌二醇对关节软骨细胞生长无影响。(5) 在植入释放17β-雌二醇的硅橡胶胶囊的雄性大鼠中,与对照大鼠相比,在6周的时间内体重增加延迟了约25%。大鼠软骨肉瘤在雌激素处理的大鼠中生长到与对照大鼠相同的大小。(6) 在新鲜分离的牛关节软骨细胞或大鼠软骨肉瘤中未检测到雌激素受体。(7) 总之,关节软骨细胞的有丝分裂率及其蛋白聚糖代谢均不受雌二醇的直接生理控制。大鼠软骨肉瘤软骨细胞的生长和生物合成活性既不依赖于激素的直接控制,也不依赖于雌二醇对第二种激素或生长因子的调节所产生的控制。